首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷癌症個人化醫學分子呈像/呈影劑核子醫學

市場調查報告書

商品編碼

1469865

全球放射治療市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Radiotheranostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年04月01日 | 出版商:

Value Market Research | 英文 236 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球放射治療市場需求預計將從 2023 年的 80.3 億美元增至 2032 年近 239.7 億美元，2024-2032 年研究期間複合年成長率為 12.92%。

放射治療學是一個新興領域，它將診斷影像和標靶放射治療結合起來進行個人化癌症治療。它涉及放射性藥物的開發和使用，這些藥物可以透過對腫瘤細胞進行治療劑量的輻射來診斷和治療癌症，同時不傷害健康組織。這種方法針對癌細胞表達的特定分子標記或受體，實現腫瘤的精確定位和治療，同時透過影像學方法（包括正子斷層掃描（PET）或單光子發射電腦斷層掃描（SPECT））監測治療反應。

市場動態

全球癌症盛行率的不斷上升刺激了對更有效和個人化治療方案的需求，導致人們對放射治療方法越來越感興趣。放射治療學將治療和診斷功能結合在單一試劑中，為標靶癌症治療和用於治療計劃和監測的精確成像提供了一種有前途的解決方案。此外，放射性藥物和影像技術的進步提高了放射治療程序的有效性和安全性，鼓勵醫療保健提供者和患者採用它們。此外，製藥公司和學術機構對研發的投資不斷增加，推動了新型放射治療劑和影像模式的創新和商業化。

此外，旨在促進精準醫療和改善癌症護理的有利政府措施和監管支持進一步刺激了放射治療市場的成長。此外，醫療保健從業者和患者對放射治療在改善治療結果和減少副作用方面的好處的認知不斷提高，這有助於市場擴張。然而，不斷變化的監管環境和定價壓力可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球放射治療市場的每個細分市場進行了包容性評估。放射治療產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

放射治療市場報告的這一部分提供了國家和區域層級細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人口統計數據以及即將到來的機會。

透過放射性同位素

碘131
碘123
鎵68
镥177
18F 配Y-90
其他

依方法

標靶治療
針對性診斷

按申請

腫瘤學（甲狀腺癌、神經內分泌腫瘤、肝細胞癌、攝護腺癌、其他）
非腫瘤學（神經系統疾病、關節炎、其他）

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲放射治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。放射治療市場的主要參與者包括 Progenics Pharmaceuticals, Inc. (Lantheus)、Telix Pharmaceuticals Limited、ITM Radiopharma、Life Molecular Imaging.、RadioMedix、IsoTherapeutics Group, LLC、Q BioMed Inc.、Nordic Nanovector ASA、Novartis AG。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：放射治療公司的競爭格局

放射治療市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
Progenics Pharmaceuticals Inc. (Lantheus)

公司簡介
公司收入
產品
最近的發展

Telix Pharmaceuticals Limited

公司簡介
公司收入
產品
最近的發展

ITM Radiopharma

公司簡介
公司收入
產品
最近的發展

Life Molecular Imaging.

公司簡介
公司收入
產品
最近的發展

RadioMedix

公司簡介
公司收入
產品
最近的發展

IsoTherapeutics Group LLC

公司簡介
公司收入
產品
最近的發展

Q BioMed Inc.

公司簡介
公司收入
產品
最近的發展

Nordic Nanovector ASA

公司簡介
公司收入
產品
最近的發展

Novartis AG

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114260

The global demand for Radiotheranostics Market is presumed to reach the market size of nearly USD 23.97 Billion by 2032 from USD 8.03 Billion in 2023 with a CAGR of 12.92% under the study period 2024 - 2032.

Radiotheranostics is an emerging field that combines diagnostic imaging and targeted radiotherapy for personalized cancer treatment. It involves the development and use of radiopharmaceuticals that can both diagnose and treat cancer by administering therapeutic doses of radiation to tumor cells while sparing healthy tissue. This approach targets specific molecular markers or receptors expressed by cancer cells, enabling precise localization and treatment of tumors while monitoring treatment response through imaging methods, including positron emission tomography (PET) or single-photon emission computed tomography (SPECT).

MARKET DYNAMICS

The increasing prevalence of cancer worldwide has spurred the demand for more effective and personalized treatment options, leading to a growing interest in radiotheranostic approaches. Radiotheranostics, which combines therapeutic and diagnostic capabilities in a single agent, offers a promising solution for targeted cancer therapy and accurate imaging for treatment planning and monitoring. Furthermore, advancements in radiopharmaceuticals and imaging technologies have enhanced the efficacy and safety of radiotheranostic procedures, encouraging their adoption by healthcare providers and patients. Additionally, the rising investments in research and development by pharmaceutical companies and academic institutions fuel the innovation and commercialization of novel radiotheranostic agents and imaging modalities.

Moreover, favorable government initiatives and regulatory support aimed at promoting precision medicine and improving cancer care are further stimulating the growth of the radiotheranostics market. Additionally, the increasing awareness among healthcare practitioners and patients about the benefits of radiotheranostics in improving treatment outcomes and reducing side effects contributes to market expansion. However, the evolving regulatory landscape and pricing pressures may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of radiotheranostics. The growth and trends of radiotheranostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the radiotheranostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Radioisotope

Iodine-131
Iodine-123
Gallium-68
Lutetium-177
18F With Y-90
Others

By Approach

Targeted Therapeutic
Targeted Diagnostic

By Application

Oncology (Thyroid Cancer, Neuroendocrine Tumors, Hepatocellular Carcinoma, Prostate Cancer, Others)
Non-Oncology (Neurological Disorders, Arthritis, Others)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Radiotheranostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Radiotheranostics market include Progenics Pharmaceuticals, Inc. (Lantheus), Telix Pharmaceuticals Limited, ITM Radiopharma, Life Molecular Imaging., RadioMedix, IsoTherapeutics Group, LLC, Q BioMed Inc., Nordic Nanovector ASA, Novartis AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. RADIOTHERANOSTICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Radioisotope
- 3.7.2 Market Attractiveness Analysis By Approach
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL RADIOTHERANOSTICS MARKET ANALYSIS BY RADIOISOTOPE

5.1. Overview By Radioisotope
5.2. Historical and Forecast Data
5.3. Analysis By Radioisotope
5.4. Iodine-131 Historic and Forecast Sales By Regions
5.5. Iodine-123 Historic and Forecast Sales By Regions
5.6. Gallium-68 Historic and Forecast Sales By Regions
5.7. Lutetium-177 Historic and Forecast Sales By Regions
5.8. 18F with Y-90 Historic and Forecast Sales By Regions
5.9. Others Historic and Forecast Sales By Regions

6. GLOBAL RADIOTHERANOSTICS MARKET ANALYSIS BY APPROACH

6.1. Overview By Approach
6.2. Historical and Forecast Data
6.3. Analysis By Approach
6.4. Targeted Therapeutic Historic and Forecast Sales By Regions
6.5. Targeted Diagnostic Historic and Forecast Sales By Regions

7. GLOBAL RADIOTHERANOSTICS MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data
7.3. Analysis By Application
7.4. Oncology (Thyroid Cancer, Neuroendocrine Tumors, Hepatocellular Carcinoma, Prostate Cancer, Others) Historic and Forecast Sales By Regions
7.5. Non-oncology (Neurological Disorders, Arthritis, Others) Historic and Forecast Sales By Regions

8. GLOBAL RADIOTHERANOSTICS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE RADIOTHERANOSTICS COMPANIES

9.1. Radiotheranostics Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF RADIOTHERANOSTICS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Progenics Pharmaceuticals Inc. (Lantheus)
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Telix Pharmaceuticals Limited
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. ITM Radiopharma
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Life Molecular Imaging.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. RadioMedix
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. IsoTherapeutics Group LLC
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Q BioMed Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Nordic Nanovector ASA
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Novartis AG
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Radioisotope (USD MN)
Iodine-131 Market Sales By Geography (USD MN)
Iodine-123 Market Sales By Geography (USD MN)
Gallium-68 Market Sales By Geography (USD MN)
Lutetium-177 Market Sales By Geography (USD MN)
18F with Y-90 Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Analysis By Approach (USD MN)
Targeted Therapeutic Market Sales By Geography (USD MN)
Targeted Diagnostic Market Sales By Geography (USD MN)
Analysis By Application (USD MN)
Oncology (Thyroid Cancer, Neuroendocrine Tumors, Hepatocellular Carcinoma, Prostate Cancer, Others) Market Sales By Geography (USD MN)
Non-oncology (Neurological Disorders, Arthritis, Others) Market Sales By Geography (USD MN)
Global Radiotheranostics Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Radiotheranostics Report
Market Research Process
Market Research Methodology
Global Radiotheranostics Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Radioisotope
Market Attractiveness Analysis By Approach
Market Attractiveness Analysis By Application
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Radioisotope (USD MN)
Iodine-131 Market Sales By Geography (USD MN)
Iodine-123 Market Sales By Geography (USD MN)
Gallium-68 Market Sales By Geography (USD MN)
Lutetium-177 Market Sales By Geography (USD MN)
18F with Y-90 Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Analysis By Approach (USD MN)
Targeted Therapeutic Market Sales By Geography (USD MN)
Targeted Diagnostic Market Sales By Geography (USD MN)
Global Market Analysis By Application (USD MN)
Oncology (Thyroid Cancer, Neuroendocrine Tumors, Hepatocellular Carcinoma, Prostate Cancer, Others) Market Sales By Geography (USD MN)
Non-oncology (Neurological Disorders, Arthritis, Others) Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis